Medical knowledge · Legal judgment · Human agency

Cerebral Palsy

Jaundice and Cerebral Palsy: Proving Medical Negligence in NY

MDLaw Firm Legal TeamJuly 23, 2026

Severe untreated jaundice can cause kernicterus — a type of brain damage that leads to athetoid cerebral palsy. This guide explains how to prove medical negligence when jaundice causes CP in New York.

<!-- META: Jaundice causing cerebral palsy: how untreated hyperbilirubinemia leads to kernicterus and CP. Proving medical negligence in New York. Call 347-524-5777. -->

Jaundice and Cerebral Palsy: Proving Medical Negligence in NY

Excerpt: Severe untreated jaundice can cause kernicterus — a type of brain damage that leads to athetoid cerebral palsy. This guide explains how to prove medical negligence when jaundice causes CP in New York.

The Connection Between Jaundice and Cerebral Palsy

Neonatal jaundice — the yellowing of a newborn's skin and eyes — is one of the most common conditions in newborns, affecting approximately 60% of full-term infants. In most cases, jaundice is mild and resolves without treatment. But when jaundice is severe and untreated, it can cause kernicterus — a devastating form of brain damage that leads to a specific type of cerebral palsy called athetoid cerebral palsy (also known as dyskinetic CP).

The tragedy is that kernicterus is almost entirely preventable. With proper screening, monitoring, and treatment (phototherapy and, in severe cases, exchange transfusion), no newborn should suffer brain damage from jaundice in a modern hospital. When it does happen, it is almost always the result of medical negligence.

If your child developed cerebral palsy after severe jaundice, this guide explains how to prove negligence and pursue a claim in New York.

[Link to: /birth-injury/kernicterus-lawyer]

What Is Neonatal Jaundice?

Jaundice occurs when bilirubin — a yellow pigment produced when red blood cells break down — accumulates in the blood. Newborns produce more bilirubin than adults because their red blood cells turn over faster, and their livers are not yet mature enough to process and eliminate it efficiently.

Types of Bilirubin

  • Indirect (unconjugated) bilirubin — The form that circulates in the blood before the liver processes it. This is the form that can cross the blood-brain barrier and cause damage.
  • Direct (conjugated) bilirubin — The form the liver has processed and is ready for elimination.

Kernicterus is caused by high levels of unconjugated bilirubin crossing the blood-brain barrier and depositing in the basal ganglia — the brain's motor control centers. This damage causes athetoid cerebral palsy, characterized by involuntary, writhing movements.

Risk Factors for Severe Jaundice

The American Academy of Pediatrics (AAP) identifies several risk factors that increase the likelihood of severe hyperbilirubinemia:

  • Prematurity — Premature babies' livers are even less mature
  • Exclusive breastfeeding — Particularly in the first week, when milk supply is being established
  • Blood type incompatibility — ABO or Rh incompatibility between mother and baby
  • G6PD deficiency — A genetic enzyme deficiency causing rapid red blood cell breakdown
  • Bruising or cephalohematoma — From a difficult delivery
  • East Asian ancestry — Higher baseline bilirubin levels
  • Sibling history — A previous child with severe jaundice

The Standard of Care for Jaundice Management

The AAP's 2022 Clinical Practice Guideline establishes the standard of care for jaundice management:

1. Risk Assessment

Every newborn should be assessed for risk factors for severe hyperbilirubinemia. This includes checking maternal blood type, reviewing the family history, and assessing for physical signs of jaundice.

2. Bilirubin Screening

The AAP recommends that every newborn receive a bilirubin measurement (either transcutaneous or serum) before discharge. This is not optional — universal screening is the standard of care.

3. Use of Bilirubin Nomograms

Bilirubin levels must be interpreted using a bilirubin nomogram that accounts for the baby's age in hours and risk factors. A bilirubin level that is acceptable at 24 hours may be dangerous at 48 hours.

4. Phototherapy

When bilirubin levels reach the threshold for phototherapy (based on the nomogram and risk factors), the standard of care requires initiating phototherapy — specialized blue light that helps convert bilirubin into a form the baby can excrete.

5. Exchange Transfusion

When bilirubin levels reach dangerously high thresholds, an exchange transfusion — replacing the baby's blood with donor blood — may be necessary. This is a hospital-level procedure that requires expertise and readiness.

6. Follow-Up Testing

After discharge, at-risk infants should have follow-up bilirubin testing within 24-72 hours, as bilirubin typically peaks at 3-5 days of life.

How Negligence Causes Kernicterus and CP

Kernicterus occurs when healthcare providers deviate from the standard of care in one or more of the following ways:

Failure to Screen

If the hospital or pediatrician did not perform a bilirubin test before discharge — or did not assess risk factors — severe jaundice may go undetected.

Failure to Interpret Results Correctly

Even when a bilirubin test is performed, the results must be interpreted using the bilirubin nomogram. Treating a high-for-age bilirubin level as "normal" or "borderline" is a deviation from the standard of care.

Failure to Initiate Phototherapy

When bilirubin levels reach the treatment threshold, phototherapy must be started promptly. Delays — due to physician nonchalance, nursing delays, or equipment unavailability — allow bilirubin to continue rising.

Failure to Perform Exchange Transfusion

When bilirubin reaches the exchange transfusion threshold, the procedure must be performed urgently. Delaying or failing to perform the transfusion allows bilirubin to cross the blood-brain barrier.

Premature Discharge

Sending a baby home before bilirubin has peaked (typically day 3-5) without a follow-up plan is dangerous. Babies can develop severe jaundice after discharge.

Failure to Provide Follow-Up

If the hospital discharged the baby without scheduling a follow-up bilirubin test within 24-72 hours, rising bilirubin may go undetected until it causes brain damage.

Proving Causation in Jaundice-CP Cases

Causation is often less contested in jaundice cases than in HIE cases, because the causal chain is well-established:

  1. Bilirubin levels — Medical records showing documented high bilirubin levels
  2. Timing — The bilirubin rise preceded the onset of neurological symptoms
  3. MRI findings — Kernicterus has a characteristic MRI pattern: injury to the globus pallidus (a part of the basal ganglia)
  4. Clinical presentation — Athetoid cerebral palsy with hearing loss (a classic kernicterus combination)

Expert Witnesses

Jaundice-CP cases require testimony from:

  • A pediatrician or neonatologist on the standard of care for jaundice management
  • A pediatric neurologist on the nature and timing of brain injury
  • A pediatric neuroradiologist to interpret MRI findings
  • An audiologist (hearing loss is common in kernicterus)

Defense Strategies and Plaintiff Counters

Defense: "The jaundice was unexpected."

Counter: The AAP guideline requires universal screening and risk assessment. If the baby had risk factors that were not identified, or if bilirubin was not tested before discharge, the defense of "unexpected" fails.

Defense: "The parents should have brought the baby back sooner."

Counter: The hospital has a duty to provide appropriate follow-up instructions and schedule a follow-up appointment. If the parents were not properly warned about the signs of severe jaundice, the hospital bears responsibility.

Defense: "The brain injury was caused by something else."

Counter: MRI findings of globus pallidus injury, combined with documented high bilirubin levels, are diagnostic of kernicterus. The defense cannot easily explain away this combination.

Statute of Limitations

Under CPLR 208, the deadline to file is generally 10 years from the date of birth.

[Link to: /birth-injury/statute-of-limitations]

Frequently Asked Questions

Can jaundice cause cerebral palsy?

Yes. Severe untreated jaundice can cause kernicterus — brain damage to the basal ganglia that leads to athetoid cerebral palsy, characterized by involuntary movements. This type of CP is almost entirely preventable with proper screening and treatment.

How is jaundice-related CP different from HIE-related CP?

Jaundice causes athetoid (dyskinetic) CP with characteristic involuntary movements and often hearing loss. HIE causes more commonly spastic CP with stiff, tight muscles. The MRI patterns also differ: kernicterus affects the globus pallidus, while HIE affects the basal ganglia and thalamus more broadly.

What is the standard of care for newborn jaundice?

The AAP requires universal bilirubin screening before discharge, risk assessment, use of bilirubin nomograms, phototherapy when levels reach treatment thresholds, exchange transfusion for dangerous levels, and follow-up testing after discharge.

How do I prove my child's CP was caused by jaundice negligence?

Key evidence includes documented high bilirubin levels, failure to screen or treat, MRI findings showing globus pallidus injury, and the clinical presentation of athetoid CP with hearing loss. Expert testimony from a pediatric neurologist and neuroradiologist is essential.

How long do I have to file a jaundice-CP lawsuit in New York?

Under CPLR 208, the deadline is generally 10 years from the child's date of birth. However, early consultation preserves evidence.


If you or a loved one has been affected by cerebral palsy from untreated jaundice in New York, contact MDLaw Firm at 347-524-5777 for a free consultation.

This article is for informational purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome. No attorney-client relationship is created by reading this article or contacting MDLaw Firm.

Author

MDLaw Firm Legal Team

MDLaw Firm Legal Team is a New York medical malpractice attorney with decades of experience litigating complex medical negligence cases. As a member of the Multi-Million Dollar Advocates Forum and Super Lawyers selectee, MDLaw Firm Legal Team focuses exclusively on representing patients harmed by medical errors in New York State courts, with a track record of multi-million-dollar verdicts and settlements.

View Attorney Profile

Have a Question About Your Case?

Get a free, confidential evaluation from our medical-legal team.

Request a Free Case Review